Table 5 Medication-related subgroup analysis for association between blood albumin level with risk of CV complications and 1-year mortality risk

1.242 (0.718, 2.150)

0.439

0.064

1.143 (0.678, 1.928)

0.615

0.009

2.131 (1.605, 2.829)

 < 0.001

0.557 (0.422, 0.734)

 < 0.001

2.173 (1.577, 2.994)

 < 0.001

0.142

0.737 (0.545, 0.997)

0.048

0.193

1.576 (1.055, 2.354)

0.026

0.520 (0.343, 0.788)

0.002

2.417 (1.439, 4.059)

 < 0.001

0.250

0.573 (0.341, 0.966)

0.036

0.500

1.675 (1.256, 2.233)

 < 0.001

0.706 (0.536, 0.930)

0.013

1.670 (1.213, 2.301)

0.002

0.239

0.732 (0.533, 1.004)

0.053

0.286

2.294 (1.538, 3.421)

 < 0.001

0.578 (0.398, 0.840)

0.004

0.957 (0.582, 1.572)

0.861

0.025

1.289 (0.805, 2.065)

0.290

0.006

1.847 (1.383, 2.467)

 < 0.001

0.628 (0.473, 0.834)

0.001

1.687 (1.228, 2.316)

0.001

0.271

0.852 (0.627, 1.157)

0.304

0.418

1.393 (0.937, 2.070)

0.102

0.687 (0.462, 1.022)

0.064

1.970 (1.171, 3.313)

0.011

0.173

0.547 (0.318, 0.943)

0.030

0.123

1.383 (1.043, 1.835)

0.025

0.877 (0.668, 1.150)

0.341

1.393 (1.023, 1.896)

0.035

0.447

0.825 (0.607, 1.122)

0.220

0.73

1.782 (1.188, 2.671)

0.005

0.768 (0.522, 1.130)

0.181

1.140 (0.647, 2.007)

0.650

0.025

0.859 (0.499, 1.481)

0.585

0.032

2.139 (1.619, 2.825)

 < 0.001

0.508 (0.385, 0.669)

 < 0.001

2.157 (1.570, 2.962)

 < 0.001

0.162

0.651 (0.480, 0.884)

0.006

0.156

1.607 (1.083, 2.386)

0.019

0.458 (0.304, 0.691)

 < 0.001

2.165 (1.327, 3.531)

0.002

0.510

0.419 (0.247, 0.712)

0.001

0.197

1.704 (1.277, 2.273)

 < 0.001

0.655 (0.497, 0.864)

0.003

1.737 (1.247, 2.421)

0.001

0.435

0.563 (0.402, 0.788)

 < 0.001

0.991

2.085 (1.440, 3.018)

 < 0.001

0.592 (0.418, 0.840)

0.003